Rapid Diagnostic Test for the Detection of SARS-CoV-2 Antigen

Request Quote

CareStart™ COVID-19 Antigen

The CareStart™ COVID-19 Antigen Test 

is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.

As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test diagnosis the COVID-19 infection on a large scale.

*Rapid results AT 10 minutes
*No lab equipment or additional instruments required
*Designed for use in point-of-care settings
*Detect SARS-CoV-2 nucleocapsid protein antigen
*Lateral flow assay
*Minimally invasive specimen collection (
Anterior nares)
*Designated as a CLIA Waived test
FDA Emergency Use Aurthorized

FACT SHEET FOR HEALTHCARE PROVIDERS
IFU (INSTRUCTIONS FOR USE)
FACT SHEET FOR PATIENTS
FDA EMERGENCY USE AUTHORIZATION
CareStart™ COVID-19 Antigen

3729 Main Street
College Park, GA, 30337

Ailm Medical LLC DBA NewNorm Platform
"Women Owned*
Website evolving in Real Time. Please excuse the construction.